Clinic
Advocate Sherman Hospital
Advocate Sherman Hospital was paid $1.18M by Medicaid between Jan 2018 and Jul 2020, across 77 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 73% of everything it billed.
33Billing provider infoADVOCATE SHERMAN HOSPITAL
ELGIN, IL 60123
ELGIN, IL 60123
33aNPI1629026364assigned 05/05/2006
33bProvider typeUrgent Care Clinic/Center
28Total paid$1.18M
24GClaims60,615
24DCodes billed77
24AFirst – last monthJan 2018 – Jul 2020
Compared with peers
Next to other Urgent Care Clinic/Center providers in Illinois
Rank by total paid#5 of 7
Median peer was paid$1.47M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RICHARDSON, KARA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,231 | $419K | |
| 2019 | 29,362 | $599K | |
| 2020 | 10,022 | $159K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 73% | 11,710 | 1,452 | $863K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3.9% | 732 | 677 | $45K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.7% | 3,074 | 2,574 | $44K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.9% | 3,588 | 3,129 | $22K |
| 97162 | 1.8% | 427 | 257 | $21K | |
| 71046 | Radiologic examination, chest; 2 views | 1.7% | 2,221 | 1,868 | $20K |
| 97161 | 1.5% | 422 | 267 | $18K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.2% | 994 | 531 | $14K |
| 80053 | Comprehensive metabolic panel | 1.2% | 4,082 | 2,862 | $14K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 2,133 | 1,738 | $13K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,372 | 3,245 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 886 | 583 | $6K |
65 more codes
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,945 | $6K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 642 | $6K |
| 73610 | <1% | 406 | $6K | |
| 73630 | <1% | 506 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 293 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 294 | $5K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,669 | $5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 40 | $4K |
| 73562 | <1% | 259 | $3K | |
| 83655 | <1% | 403 | $3K | |
| 80061 | Lipid panel | <1% | 1,647 | $3K |
| 74018 | <1% | 320 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 87 | $3K |
| 87081 | <1% | 1,984 | $3K | |
| 84439 | <1% | 1,049 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,279 | $2K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 278 | $2K |
| 87186 | <1% | 498 | $2K | |
| 85610 | <1% | 1,313 | $2K | |
| 81003 | <1% | 3,063 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 856 | $2K |
| 73030 | <1% | 114 | $2K | |
| 81001 | <1% | 1,418 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 388 | $1K |
| 81025 | <1% | 1,389 | $1K | |
| 29125 | <1% | 44 | $964.80 | |
| 87807 | <1% | 327 | $808.54 | |
| 85027 | <1% | 563 | $780.65 | |
| 73110 | <1% | 90 | $735.71 | |
| 86703 | <1% | 104 | $703.44 | |
| 73140 | <1% | 94 | $450.88 | |
| 73130 | <1% | 46 | $446.41 | |
| 29515 | <1% | 12 | $383.68 | |
| 84481 | <1% | 149 | $362.29 | |
| 85651 | <1% | 234 | $294.83 | |
| 87205 | <1% | 318 | $257.04 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 140 | $241.86 |
| 87070 | <1% | 190 | $235.32 | |
| 87808 | <1% | 80 | $223.00 | |
| 72100 | <1% | 15 | $193.73 | |
| 82570 | <1% | 171 | $170.68 | |
| 86038 | <1% | 27 | $141.15 | |
| 83735 | <1% | 97 | $135.17 | |
| 36416 | <1% | 276 | $119.81 | |
| 73564 | <1% | 13 | $118.82 | |
| 73080 | <1% | 12 | $115.06 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 66 | $110.12 |
| 84156 | <1% | 149 | $71.67 | |
| 86140 | <1% | 51 | $61.04 | |
| 82607 | <1% | 15 | $47.20 | |
| 85007 | <1% | 49 | $41.00 | |
| 82728 | <1% | 27 | $35.00 | |
| 84550 | <1% | 23 | $26.46 | |
| 86308 | <1% | 26 | $26.16 | |
| 86850 | <1% | 18 | $22.17 | |
| 82247 | <1% | 17 | $22.13 | |
| 83540 | <1% | 27 | $15.68 | |
| 82248 | <1% | 16 | $13.05 | |
| 86900 | <1% | 18 | $12.07 | |
| 86901 | <1% | 18 | $11.62 | |
| 85014 | <1% | 40 | $9.16 | |
| 85018 | <1% | 41 | $5.74 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 43 | $3.57 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 169 | $0.00 |
| 87077 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRICHARDSON, KARA (VP MANAGED HEALTH)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.